181 related articles for article (PubMed ID: 37253553)
1. Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLE.
Cody EM; Wilson BE; Ogbu EA; Huggins JL; Chen C; Qiu T; Ting TV; Flores F; Huang B; Brunner HI
Lupus Sci Med; 2023 May; 10(1):. PubMed ID: 37253553
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of achieving lupus low disease activity state and damage accrual in childhood-onset systemic lupus erythematosus.
Na Nakorn K; Piyaphanee N; Sukharomana M; Pinpatanapong R; Charuvanij S
Clin Rheumatol; 2023 Jun; 42(6):1655-1664. PubMed ID: 36780064
[TBL] [Abstract][Full Text] [Related]
3. First validation of the childhood lupus low disease activity state (cLLDAS) definition in a real-life longitudinal cSLE cohort.
Bergkamp SC; Kanagasabapathy T; Gruppen MP; Kuijpers TW; Rashid AN; van den Berg JM; Schonenberg-Meinema D
Clin Immunol; 2024 May; 262():110172. PubMed ID: 38490344
[TBL] [Abstract][Full Text] [Related]
4. Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS).
Abdelhady EI; Rabie M; Hassan RA
Clin Rheumatol; 2021 Nov; 40(11):4553-4558. PubMed ID: 34142298
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis.
Qiu S; Zhang H; Yu S; Yang Q; Zhang G; Yang H; Li Q; Wang M
Pediatr Nephrol; 2022 Feb; 37(2):367-376. PubMed ID: 34379208
[TBL] [Abstract][Full Text] [Related]
6. Determinants and protective associations of the lupus low disease activity state in a prospective Chinese cohort.
Hao Y; Oon S; Ji L; Gao D; Fan Y; Geng Y; Zhang X; Li G; Morand EF; Nikpour M; Zhang Z
Clin Rheumatol; 2022 Feb; 41(2):357-366. PubMed ID: 34595670
[TBL] [Abstract][Full Text] [Related]
7. Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission.
Zen M; Iaccarino L; Gatto M; Saccon F; Larosa M; Ghirardello A; Punzi L; Doria A
Ann Rheum Dis; 2018 Jan; 77(1):104-110. PubMed ID: 28970217
[TBL] [Abstract][Full Text] [Related]
8. Lupus low disease activity state within 12 months is associated with favourable outcomes in severely active systemic lupus erythematosus.
Kikuchi J; Hanaoka H; Saito S; Oshige T; Hiramoto K; Kaneko Y; Takeuchi T
Rheumatology (Oxford); 2022 Aug; 61(9):3777-3791. PubMed ID: 35015824
[TBL] [Abstract][Full Text] [Related]
9. Treatment Target in Newly Diagnosed Systemic Lupus Erythematosus: The Association of Lupus Low Disease Activity State and Remission With Lower Accrual of Early Damage.
Floris A; Piga M; Perra D; Chessa E; Congia M; Mathieu A; Cauli A
Arthritis Care Res (Hoboken); 2020 Dec; 72(12):1794-1799. PubMed ID: 31600023
[TBL] [Abstract][Full Text] [Related]
10. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
Cho J; Shen L; Huq M; Kandane-Rathnayake R; Golder V; Louthrenoo W; Chen YH; Hamijoyo L; Luo SF; Wu YJ; Zamora L; Li Z; Sockalingam S; Katsumata Y; Harigai M; Hao Y; Zhang Z; Basnayake D; Chan M; Kikuchi J; Takeuchi T; Bae SC; Oon S; O'Neill S; Goldblatt F; Ng KPL; Law A; Tugnet N; Kumar S; Tee C; Tee M; Ohkubo N; Tanaka Y; Navarra SV; Lau CS; Hoi A; Morand EF; Nikpour M; Lateef A;
Lancet Rheumatol; 2023 Oct; 5(10):e584-e593. PubMed ID: 38251484
[TBL] [Abstract][Full Text] [Related]
11. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study.
Ramirez GA; Canti V; Moiola L; Magnoni M; Rovere-Querini P; Coletto LA; Dagna L; Manfredi AA; Bozzolo EP
Int J Rheum Dis; 2019 Sep; 22(9):1752-1761. PubMed ID: 31379114
[TBL] [Abstract][Full Text] [Related]
12. Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus.
Smith EMD; Tharmaratnam K; Al-Abadi E; Armon K; Bailey K; Brennan M; Ciurtin C; Gardner-Medwin J; Haslam KE; Hawley D; Leahy A; Leone V; Malik G; McLaren Z; Pilkington C; Ramanan AV; Rangaraj S; Ratcliffe A; Riley P; Sen E; Sridhar A; Wilkinson N; Hedrich CM; Jorgensen A; Beresford MW
Rheumatology (Oxford); 2022 Aug; 61(8):3378-3389. PubMed ID: 34894234
[TBL] [Abstract][Full Text] [Related]
13. Targeting DORIS Remission and LLDAS in SLE: A Review.
Parra Sánchez AR; van Vollenhoven RF; Morand EF; Bruce IN; Kandane-Rathnayake R; Weiss G; Tummala R; Al-Mossawi H; Sorrentino A
Rheumatol Ther; 2023 Dec; 10(6):1459-1477. PubMed ID: 37798595
[TBL] [Abstract][Full Text] [Related]
14. Lupus low disease activity state as a treatment target for pediatric patients with lupus nephritis.
Kisaoglu H; Baba O; Kalyoncu M
Pediatr Nephrol; 2023 Apr; 38(4):1167-1175. PubMed ID: 36156735
[TBL] [Abstract][Full Text] [Related]
15. LLDAS is an attainable treat-to-target goal in childhood-onset SLE.
Wahadat MJ; van den Berg L; Timmermans D; van Rijswijk K; van Dijk-Hummelman A; Bakx S; Verkaaik M; Versnel MA; Kamphuis S
Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34969874
[TBL] [Abstract][Full Text] [Related]
16. PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS).
Smith EMD; Aggarwal A; Ainsworth J; Al-Abadi E; Avcin T; Bortey L; Burnham J; Ciurtin C; Hedrich CM; Kamphuis S; Lambert L; Levy DM; Lewandowski L; Maxwell N; Morand E; Ozen S; Pain CE; Ravelli A; Saad Magalhaes C; Pilkington C; Schonenberg-Meinema D; Scott C; Tullus K; Beresford MW;
Clin Immunol; 2023 May; 250():109296. PubMed ID: 36934849
[TBL] [Abstract][Full Text] [Related]
17. Remission and low disease activity in Polish patients with systemic lupus erythematosus - real-life, five-year follow-up outcomes.
Pawlak-Buś K; Schmidt W; Leszczyński P
Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):949-959. PubMed ID: 36808341
[TBL] [Abstract][Full Text] [Related]
18. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
Front Immunol; 2022; 13():885307. PubMed ID: 35720325
[TBL] [Abstract][Full Text] [Related]
19. Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus.
Piga M; Floris A; Cappellazzo G; Chessa E; Congia M; Mathieu A; Cauli A
Arthritis Res Ther; 2017 Nov; 19(1):247. PubMed ID: 29126432
[TBL] [Abstract][Full Text] [Related]
20. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
Srivastava P; Abujam B; Misra R; Lawrence A; Agarwal V; Aggarwal A
Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
